Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation

Ferrara, 2009, Graft-versus-host disease, Lancet, 373, 1550, 10.1016/S0140-6736(09)60237-3 Gratwohl, 2005, Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time, Bone Marrow Transplant, 36, 757, 10.1038/sj.bmt.1705140 Holler, 2014, Metagenomic analysis of the stool microbiome in patients receiving allogeneic SCT: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal GvHD, Biol Blood Marrow Transplant, 20, 640, 10.1016/j.bbmt.2014.01.030 Jenq, 2012, Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation, J Exp Med, 209, 903, 10.1084/jem.20112408 Taur, 2014, The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation, Blood, 124, 1174, 10.1182/blood-2014-02-554725 Weber, 2015, Low urinary indoxyl sulfate levels early after ASCT reflect a disrupted microbiome and are associated with poor outcome, Blood, 126, 1723, 10.1182/blood-2015-04-638858 Freifeld, 2011, Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america, Clin Infect Dis, 52, e56, 10.1093/cid/cir073 Averbuch, 2013, European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia, Haematologica, 98, 1826, 10.3324/haematol.2013.091025 Jenq, 2015, Intestinal blautia is associated with reduced death from graft-versus-host disease, Biol Blood Marrow Transplant, 21, 1373, 10.1016/j.bbmt.2015.04.016 Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540 Schloss, 2009, Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities, Appl Environ Microbiol, 75, 7537, 10.1128/AEM.01541-09 Schloss, 2011, Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies, PLoS ONE, 6, e27310, 10.1371/journal.pone.0027310 Wang, 2007, Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy, Appl Environ Microbiol, 73, 5261, 10.1128/AEM.00062-07 DeSantis, 2006, Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB, Appl Environ Microbiol, 72, 5069, 10.1128/AEM.03006-05 Scrucca, 2007, Competing risk analysis using R: an easy guide for clinicians, Bone Marrow Transplant, 40, 381, 10.1038/sj.bmt.1705727 Weber, 2016, Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation, Bone Marrow Transplant, 51, 1087, 10.1038/bmt.2016.66 Goldstein, 2014, Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrence, Antimicrob Agents Chemother, 58, 1187, 10.1128/AAC.02184-13 Dethlefsen, 2008, The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing, PLoS Biol, 6, e280, 10.1371/journal.pbio.0060280 DuPont, 2016, Review article: the antimicrobial effects of rifaximin on the gut microbiota, Aliment Pharmacol Ther, 43, 3, 10.1111/apt.13434 Shono, 2015, Intestinal microbiota-related effects on graft-versus-host disease, Int J Hematol, 101, 428, 10.1007/s12185-015-1781-5 Shono, 2016, Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice, Sci Transl Med, 8, 339-371, 10.1126/scitranslmed.aaf2311 Eriguchi, 2015, Decreased secretion of Paneth cell alpha-defensins in graft-versus-host disease, Transpl Infect Dis, 17, 702, 10.1111/tid.12423 Brandl, 2008, Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits, Nature, 455, 804, 10.1038/nature07250 Narushima, 2014, Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia, Gut Microbes, 5, 333, 10.4161/gmic.28572 Atarashi, 2013, Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota, Nature, 500, 232, 10.1038/nature12331 Furusawa, 2013, Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells, Nature, 504, 446, 10.1038/nature12721 McDermott, 2014, The microbiome and regulation of mucosal immunity, Immunology, 142, 24, 10.1111/imm.12231 Reynolds, 2013, A case for antibiotic perturbation of the microbiota leading to allergy development, Exp Rev Clin Immunol, 9, 1019, 10.1586/1744666X.2013.851603 Kuo, 2013, Early life exposure to antibiotics and the risk of childhood allergic diseases: an update from the perspective of the hygiene hypothesis, J Microbiol Immunol Infect, 46, 320, 10.1016/j.jmii.2013.04.005 Viaud, 2014, Why should we need the gut microbiota to respond to cancer therapies?, Oncoimmunology, 3, e27574, 10.4161/onci.27574 Viaud, 2013, The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide, Science, 342, 971, 10.1126/science.1240537 Mattarollo, 2011, Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors, Cancer Res, 71, 4809, 10.1158/0008-5472.CAN-11-0753